32.60%
The results of the final votes regarding all matters subject to a vote during the Meeting will also be made available on SEDAR (www.sedar.com).
About Knight Therapeutics Inc.
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing innovative pharmaceutical products for Canada and Latin America. Knight owns Biotoscana Investments S.A., a pan-Latin American specialty pharmaceutical company. Knight Therapeutics Inc. s shares trade on TSX under the symbol GUD. For more information about Knight Therapeutics Inc., please visit the company s web site at www.gud-knight.com or www.sedar.com.
Knight Therapeutics Reports First Quarter 2021 Results
Knight Therapeutics Inc. a leading pan-American specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2021. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified. Q1 2021 Highlights Financials Revenues were $46,069, an increase of $230 or 1% over prior year. Gross margin generated of …
Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2021. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified.
Knight Therapeutics Announces Leadership Change
May 13, 2021 09:23 ET | Source: Knight Therapeutics Knight Therapeutics
- GUD to Great -
MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) Knight Therapeutics Inc. (TSX: GUD) ( Knight ) is pleased to announce that Samira Sakhia will assume the role of President and Chief Executive Officer, Knight Therapeutics Inc., effective September 1, 2021. Ms. Sakhia currently serves as Knight’s President and Chief Operating Officer.
Jonathan Ross Goodman will assume the role of Executive Chairman and will help direct Knight’s strategy through his role as Executive Chairman of the Board and by providing the full benefit of his 27 years of experience, leadership and guidance. At 17.2% ownership, Jonathan remains Knight’s largest shareholder.
Knight to Present at the 2021 RBC Capital Markets Global Healthcare Conference
Knight Therapeutics Inc. a leading pan-American specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Operating Officer, is scheduled to participate in a fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021 at 8:35 am ET. A live webcast of the event will be available at the following link: Event . A copy of the presentation will be …
Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Operating Officer, is scheduled to participate in a fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021 at 8:35 am ET. A live webcast of the event will be available at the following link: Event . A copy of the presentation will be available at www.gud-knight.com .
U.S. CPI in Focus Next Week
U.S. CPI in Focus Next Week
Monday
Duke Energy (NYSE: DUK) (Q4) EPS projected for $1.24, compared to $1.14 the prior-year quarter.
Marriott International, Inc. (NASDAQ: MAR) (Q1) EPS projected for three cents, compared to 26 cents the prior-year quarter.
BioNTech SE (NASDAQ: BNTX) (Q1) EPS projected for $3.44, compared to a loss of 26 cents inthe prior-year quarter.
Featured Earnings
5N Plus Inc. (T.VNP) (Q1) EPS projected of four cents, identical to the prior-year quarter.
Finning International Inc. (T.FTT) (Q1) EPS projected for 36 cents, compared to 38 cents in the prior-year quarter.
Sleep Country Canada Holdings Inc. (T.ZZZ) (Q1) EPS projected for 21 cents, compared to 74 cents in the prior-year quarter.